Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -239,284 | -141,965 | -54,659 | -74,352 | -10,233 |
| Depreciation Amortization | 776 | 627 | 423 | 265 | 11 |
| Accounts receivable | N/A | 8,053 | 799 | -10,612 | N/A |
| Accounts payable and accrued liabilities | 2,806 | 4,305 | 10,210 | 395 | 87 |
| Other Working Capital | -11,073 | 24,792 | -8,331 | 9,981 | 306 |
| Other Operating Activity | 92,307 | 26,985 | -3,490 | 30,311 | 8,005 |
| Operating Cash Flow | $-154,468 | $-77,203 | $-55,048 | $-44,012 | $-1,824 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,181 | -1,292 | -628 | -1,062 | -693 |
| Purchase Of Investment | -214,806 | -132,259 | -49,347 | 0 | N/A |
| Sale Of Investment | 133,222 | 70,277 | 8,446 | 0 | N/A |
| Other Investing Activity | -3,098 | -1 | -2 | -159 | -1,053 |
| Investing Cash Flow | $-85,863 | $-63,275 | $-41,531 | $-1,221 | $-1,746 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 150 |
| Common Stock Issued | 233,361 | 135,973 | 2,215 | 129,259 | 56,741 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 61 |
| Financing Cash Flow | $233,361 | $135,973 | $2,215 | $129,259 | $56,952 |
| Beginning Cash Position | 38,539 | 43,044 | 137,408 | 53,382 | N/A |
| End Cash Position | 31,569 | 38,539 | 43,044 | 137,408 | 53,382 |
| Net Cash Flow | $-6,970 | $-4,505 | $-94,364 | $84,026 | $53,382 |
| Free Cash Flow | |||||
| Operating Cash Flow | -154,468 | -77,203 | -55,048 | -44,012 | -1,824 |
| Capital Expenditure | -1,181 | -1,292 | -628 | -1,062 | -693 |
| Free Cash Flow | -155,649 | -78,495 | -55,676 | -45,074 | -2,517 |